NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.47
+0.11 (0.67%)
At close: Jun 26, 2026, 4:00 PM EDT
16.47
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
NeuroPace Employees
NeuroPace had 220 employees as of March 31, 2026. The number of employees increased by 11 or 5.26% since the number was last reported on December 31, 2025.
Employees
220
Change
11
Growth
5.26%
Revenue / Employee
$452,409
Profits / Employee
-$98,023
Market Cap
561.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,387 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 678 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| SS Innovations International | 483 |
| Cerus | 275 |
| ClearPoint Neuro | 172 |
NPCE News
- 22 days ago - NeuroPace Transcript: AGM 2026 - Transcripts
- 4 weeks ago - NeuroPace announces FDA approval of ECoG Assistant - TheFly
- 4 weeks ago - NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting - Business Wire
- 4 weeks ago - NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care - Business Wire
- 6 weeks ago - NeuroPace price target raised to $20 from $19 at H.C. Wainwright - TheFly
- 6 weeks ago - NeuroPace reports Q1 EPS (20c), consensus (23c) - TheFly
- 6 weeks ago - NeuroPace raises FY26 revenue view to $99M-$101M from $98M-$100M - TheFly
- 6 weeks ago - NeuroPace Earnings Call Transcript: Q1 2026 - Transcripts